{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:19:20Z","timestamp":1771651160464,"version":"3.50.1"},"reference-count":55,"publisher":"SLACK, Inc.","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Ann"],"published-print":{"date-parts":[[2015,9]]},"abstract":"<jats:p>\n            Polycystic ovary syndrome (PCOS) is a common endocrine disorder in adolescent girls that has both reproductive and metabolic implications. Patients with PCOS typically present to their pediatrician for evaluation of menstrual irregularity and\/or signs of hyperandrogenism, such as hirsutism and acne. The diagnosis of PCOS is made by clinical symptoms and laboratory evaluation. Because of the long-term health consequences that can accompany the disorder, pediatricians should consider PCOS in their initial evaluation of menstrual irregularity. Lifestyle modification is the cornerstone of treatment for girls with PCOS; however, hormonal medication such as oral contraceptive pills and insulin-sensitizing agents are useful and effective adjuncts to therapy. The goals of treatment for girls with PCOS are to improve clinical manifestations of the disorder, health-related quality of life, and long-term health outcomes.\n            <jats:bold>\n              [\n              <jats:italic>Pediatr Ann<\/jats:italic>\n              . 2015;44(9):e223\u2013e230.]\n            <\/jats:bold>\n          <\/jats:p>","DOI":"10.3928\/00904481-20150910-10","type":"journal-article","created":{"date-parts":[[2015,9,22]],"date-time":"2015-09-22T12:34:05Z","timestamp":1442925245000},"source":"Crossref","is-referenced-by-count":13,"title":["Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent Girls"],"prefix":"10.3928","volume":"44","author":[{"given":"Erin","family":"Lanzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Monge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Trent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-032046"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(00)01662-9"},{"issue":"9","key":"e_1_3_1_4_2","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer ES","year":"1998","unstructured":"Knochenhauer ES. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83(9):3078\u20133082.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2008.61"},{"key":"e_1_3_1_6_2","volume-title":"Emans, Laufer, Goldstein\u2019s Pediatric & Adolescent Gynecology","author":"Emans S","year":"1998","unstructured":"Emans S, Laufer M. Emans, Laufer, Goldstein\u2019s Pediatric & Adolescent Gynecology. 4th ed. Philadelphia, PA: Lippincott-Raven; 1998.","edition":"4"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1666"},{"issue":"2","key":"e_1_3_1_8_2","first-page":"159","article-title":"The percentages of endometrial hyperplasia and endometrial cancer among polycystic ovary syndrome (PCOS) patients presenting with abnormal menstrual pattern","volume":"97","author":"Prakansamut N","year":"2014","unstructured":"Prakansamut N, Sirayapiwat P, Triratanachat S. The percentages of endometrial hyperplasia and endometrial cancer among polycystic ovary syndrome (PCOS) patients presenting with abnormal menstrual pattern. J Med Assoc Thai. 2014;97(2):159\u2013164.","journal-title":"J Med Assoc Thai"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1586\/14737167.7.6.597"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1367\/A04-130R.1"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-3188(02)00205-X"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(15)30642-6"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)54291-5"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2004.01945.x"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2011-1034"},{"key":"e_1_3_1_16_2","first-page":"377","volume-title":"Polycystic Ovary Syndrome","author":"Zawadski J","year":"1995","unstructured":"Zawadski J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome; towards a rational approach. In: , Dunaif A, Givens J, Haseltine F, eds. Polycystic Ovary Syndrome. Hoboken, NJ: Blackwell Scientific; 1995:377\u2013384."},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-21-11-1440"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1997.00099.x"},{"issue":"5","key":"e_1_3_1_19_2","first-page":"1285","article-title":"Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism","volume":"13","author":"Rosenfield RL","year":"2000","unstructured":"Rosenfield RL, Ghai K, Ehrmann DA, Barnes RB. Diagnosis of the polycystic ovary syndrome in adolescence: comparison of adolescent and adult hyperandrogenism. J Pediatr Endocrinol Metab. 2000;13(Suppl 5):1285\u20131289.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0178"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.03.001"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/des309"},{"issue":"8","key":"e_1_3_1_24_2","first-page":"2691","article-title":"Anovulation after precocious pubarche: early markers and time course in adolescence","volume":"84","author":"Ibanez L","year":"1999","unstructured":"Ibanez L, de Zegher F, Potau N. Anovulation after precocious pubarche: early markers and time course in adolescence. J Clin Endocrinol Metab. 1999;84(8):2691\u20132695.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"e_1_3_1_25_2","first-page":"119","article-title":"Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome","volume":"79","author":"Apter D","year":"1994","unstructured":"Apter D, Butzow T, Laughlin GA, Yen SS. Accelerated 24-hour luteinizing hormone pulsatile activity in adolescent girls with ovarian hyperandrogenism: relevance to the developmental phase of polycystic ovarian syndrome. J Clin Endocrinol Metab. 1994;79(1):119\u2013125.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199608293350902"},{"issue":"2","key":"e_1_3_1_27_2","first-page":"582","article-title":"Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone","volume":"83","author":"Pastor CL","year":"1998","unstructured":"Pastor CL, Griffin-Korf ML, Aloi JA, Evans WS, Marshall JC. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab. 1998;83(2):582\u2013590.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.2.310"},{"issue":"7","key":"e_1_3_1_29_2","first-page":"2248","article-title":"Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome","volume":"82","author":"Taylor AE","year":"1997","unstructured":"Taylor AE, McCourt B, Martin KA, et al. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997;82(7):2248\u20132256.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2015.5.11112"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2014-0307"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.293.6543.355"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1549"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-5448.2012.00902.x"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/108624"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpag.2011.01.002"},{"issue":"7","key":"e_1_3_1_37_2","first-page":"CD007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","author":"Moran LJ","year":"2011","unstructured":"Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2011;(7):CD007506.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0461"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1186\/1687-9856-2011-9"},{"key":"e_1_3_1_40_2","first-page":"1","article-title":"Hormonal contraceptive choice for women with PCOS: a systematic review of randomized trials and observational studies","author":"Mendoza N","year":"2014","unstructured":"Mendoza N, Simoncini T, Genazzani AD. Hormonal contraceptive choice for women with PCOS: a systematic review of randomized trials and observational studies. Gynecol Endocrinol. 2014; 1\u201311. [Epub ahead of print].","journal-title":"Gynecol Endocrinol"},{"issue":"05","key":"e_1_3_1_41_2","first-page":"1","article-title":"U.S. selected practice recommendations for contraceptive use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use","volume":"62","author":"Division of Reproductive Health","year":"2013","unstructured":"Division of Reproductive HealthNational Center for Chronic Disease Prevention and Health PromotionCenters for Disease Control and Prevention (CDC). U.S. selected practice recommendations for contraceptive use, 2013: adapted from the World Health Organization selected practice recommendations for contraceptive use, 2nd edition. MMWR Recomm Rep. 2013;62(RR-05):1\u201360.","journal-title":"MMWR Recomm Rep"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2015.5191"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-2299"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/jfprhc-2011-100175"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sder.2009.04.003"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G025"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2013.04.016"},{"key":"e_1_3_1_48_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-72-5-1008"},{"key":"e_1_3_1_49_2","doi-asserted-by":"publisher","DOI":"10.3928\/00904481-20090201-09"},{"key":"e_1_3_1_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dei311"},{"issue":"1","key":"e_1_3_1_51_2","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","author":"Tang T","year":"2010","unstructured":"Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2010;(1):CD003053.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2005.02.012"},{"key":"e_1_3_1_53_2","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2014.921673"},{"key":"e_1_3_1_54_2","unstructured":"2013 Sexually Transmitted Diseases Surveillance: STDs in adolescents and young adults. http:\/\/www.cdc.gov\/std\/stats13\/adol.htm. Accessed August 13 2015."},{"issue":"4","key":"e_1_3_1_55_2","first-page":"219","article-title":"Effect of pelvic inflammatory disease on fertility","volume":"8","author":"Westrom L","year":"1995","unstructured":"Westrom L. Effect of pelvic inflammatory disease on fertility. Venereology. 1995;8(4):219\u2013222.","journal-title":"Venereology"},{"key":"e_1_3_1_56_2","unstructured":"U.S. Department of Health and Human Services. The affordable care act. http:\/\/www.hhs.gov\/healthcare\/rights\/law\/index.html. Accessed August 13 2015."}],"container-title":["Pediatric Annals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/doiresolver?doi=10.3928\/00904481-20150910-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T13:25:26Z","timestamp":1683120326000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/00904481-20150910-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["10.3928\/00904481-20150910-10"],"URL":"https:\/\/doi.org\/10.3928\/00904481-20150910-10","relation":{},"ISSN":["0090-4481","1938-2359"],"issn-type":[{"value":"0090-4481","type":"print"},{"value":"1938-2359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}